Table 1 Characteristics of patients enrolled in the two treatment groups.

Age

Mean

59.71

52.10

SD (y/o)

9.92

11.26

Median

59

53

Range

(39-80)

(32-75)

Surgery

Quadrantectomy

41 (100%)

30 (100%)

LAD

25 (61%)

18 (60%)

S.Linf

16 (39%)

12 (40%)

Hystologic type

Ductal

35 (85%)

22 (73%)

Lobular

2 (5%)

1 (4%)

Others

4 (10%)

7 (23%)

Chemiotherapy

Yes

19 (46.4%)

15 (50%)

No

22 (53.6%)

15 (50%)

Hormone therapy

Yes

31 (75.6%)

21 (70%)

No

10 (24.4%)

9 (30%)

Breast volume

> 500 cc

71 (75.5%)

46 (71%)

≤ 500 cc

23 (24.5%)

19 (29%)

Breast maximum dose

≤ 107%

8 (19.5%)

4 (13.3%)

> 107% < 110%

26 (63.5%)

19 (63.4%)

≥ 110%

7 (17%)

7 (23.3%)